Home / Inspections / 1265843

1265843

Rigel Pharmaceuticals Inc — FEI 3004865166

Inspection Details

Classification: No Action Indicated (NAI) (NAI)
End Date: March 28, 2025
Fiscal Year: 2025
Product Type: Drugs
Project Area: Drug Quality Assurance
Location: South San Francisco, CA (United States)